Innovative Medical Solutions Unveiled at the ASSH Annual Meeting
Loci Orthopaedics Ltd, an innovative company in the field of clinical-stage orthopaedic medical devices, is thrilled to announce its participation in the prestigious 79th Annual Meeting of the American Society for Surgery of the Hand (ASSH). This notable event will take place in the lively city of Minneapolis, where specialists from the world of hand and upper extremity surgery will gather to share their expertise.
Connecting with Leading Surgical Experts
Professor Filip Stockmans, a member of the Scientific Advisory Board and Primary Clinical Trial Investigator, is scheduled to speak at the International Wrist Investigators Workshop. This forum offers a vital chance for engaging discussions about the latest innovations and techniques in hand surgery. The ASSH is well-known for its commitment to improving surgical practices through education, advocacy, and research.
New Perspectives on Thumb Arthritis Treatment
During the workshop, Professor Stockmans discussed the widespread challenges in treating thumb base-joint arthritis. He pointed out that while resection arthroplasty of the trapezium is still commonly performed, total joint arthroplasty might offer a more effective alternative by preventing thumb shortening—a frequent side effect of the traditional approach. A thorough understanding of these surgical choices is crucial for enhancing patient care.
The InDx Implant System from Loci Orthopaedics is a groundbreaking half-joint replacement device that stands out in this context. Designed to preserve the trapezium, it seeks to mimic the natural movement of the thumb. Its dual mobility design aims to tackle the notable risks of dislocations and cup loosening that often affect conventional implants, thus promising a greater chance of surgical success.
Hope for Future Patient Care
Barry Russell, CEO of Loci Orthopaedics, expressed his excitement over the encouraging early findings from their clinical studies. He highlighted that the InDx Implant System could greatly enhance the lives of countless patients suffering from thumb base-joint arthritis, a condition that can profoundly impact one’s quality of life.
At the ASSH meeting, experts and key figures from the surgical community will come together to share their insights and progress. Loci’s participation in this prestigious gathering underscores its dedication to innovation and collaboration, fostering vital relationships aimed at enhancing patient care.
Tackling a Global Health Challenge
Loci Orthopaedics aims to address significant unmet clinical needs in the field of orthopaedic extremities. With an estimated 5% of populations in the US and EU affected by thumb joint arthritis—translating to around 100 million people globally—the company understands the pressing necessity for effective treatments. The InDx Implant is thoughtfully designed to promote natural movement and relieve discomfort, marking a significant step forward in orthopaedic solutions.
Recent Achievements and Future Aspirations
The company recently reached key funding milestones, successfully completing an oversubscribed €12.8 million Series A financing round. This achievement is notable as it represents the largest fundraising effort in medical technology in Ireland this year, demonstrating strong investor confidence in the company's vision and innovations.
With backing from prominent investors like Seroba, Johnson & Johnson Innovation, and the European Innovation Council Fund, this round of funding brings Loci’s total financing to over €22 million. These resources will boost its operational capabilities, expand clinical research activities, and facilitate regulatory approvals, setting the stage for Loci Orthopaedics' future commercial success.
About Loci Orthopaedics
Loci Orthopaedics was founded by Mr. Gerry Clarke and Dr. Brendan Boland as a spin-out from distinguished academic institutions. The company's mission is to develop advanced orthopaedic solutions that meet critical clinical needs. Through evidence-based design, Loci strives to provide optimal functionality and restore natural movement, ultimately enhancing clinical outcomes for patients.
With ongoing advancements and a commitment to innovation in the orthopaedic sector, Loci Orthopaedics is well-positioned to lead the way in improving patient care and transforming treatment options for those suffering from debilitating conditions like thumb base-joint arthritis.
Frequently Asked Questions
What is Loci Orthopaedics known for?
Loci Orthopaedics is recognized for its groundbreaking medical device solutions that focus on orthopaedic conditions, particularly thumb base-joint arthritis.
What is the InDx Implant System?
The InDx Implant System is an advanced hemi-arthroplasty implant designed to mimic the natural mechanics of the thumb joint, aimed at reducing dislocation and improving surgical results.
What recent funding milestone did Loci Orthopaedics achieve?
Loci Orthopaedics recently completed a €12.8 million oversubscribed Series A financing round, a significant achievement in medical technology fundraising in Ireland for the year.
Who will present at the ASSH Annual Meeting?
Professor Filip Stockmans, a vital member of Loci Orthopaedics' Scientific Advisory Board, will discuss advancements in surgical techniques for thumb arthritis at the ASSH Annual Meeting.
What is the significance of the ASSH Annual Meeting?
The ASSH Annual Meeting is a vital platform for leading experts to share knowledge, advancements, and techniques in hand surgery, fostering collaboration and education across the field.
